Valuation Amgen Inc. Buenos Aires S.E.

Stocks

End-of-day quote Buenos Aires S.E. 2026-10-14			5-day change	1st Jan Change
22,920.00 ^ARS	+3.62%		+3.29%	+37.49%

06:46am	Goldman Sachs Adjusts Price Target on Amgen to $481 From $475	MT
10-13	Goldman Sachs Adjusts Price Target on Amgen to $475 From $450	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	126,718	140,139	154,142	140,103	176,250	230,369	-	-
Change	-	10.59%	9.99%	-9.11%	25.8%	30.71%	-	-
Enterprise Value (EV) ¹	151,990	169,779	207,811	188,229	221,725	271,726	265,847	260,822
Change	-	11.7%	22.4%	-9.42%	17.8%	22.55%	-2.16%	-1.89%
P/E	21.9x	21.7x	23.1x	34.5x	23x	27.1x	24.1x	23.1x
PBR	18.7x	38.3x	24.7x	23.8x	20.4x	20.6x	16.7x	13.4x
PEG	-	1.2x	7.36x	-0.9x	0.3x	2.5x	2x	5.36x
Capitalization / Revenue	4.88x	5.32x	5.47x	4.19x	4.8x	5.91x	5.7x	5.51x
EV / Revenue	5.85x	6.45x	7.37x	5.63x	6.03x	6.97x	6.58x	6.24x
EV / EBITDA	9.61x	10.5x	11.9x	9.13x	10.4x	12.5x	11.9x	11.6x
EV / EBIT	12.2x	13.3x	15.5x	12.5x	13.7x	16x	15x	14.1x
EV / FCF	18.1x	19.3x	28.2x	18.1x	27.4x	24.5x	17.8x	16.7x
FCF Yield	5.51%	5.17%	3.54%	5.52%	3.65%	4.09%	5.61%	5.99%
Dividend per Share ²	7.04	7.76	8.52	9	9.52	10.09	10.66	11.12
Rate of return	3.13%	2.95%	2.96%	3.45%	2.91%	2.37%	2.5%	2.61%
EPS ²	10.28	12.11	12.49	7.56	14.23	15.75	17.65	18.41
Distribution rate	68.5%	64.1%	68.2%	119%	66.9%	64%	60.4%	60.4%
Net sales ¹	25,979	26,323	28,190	33,424	36,751	38,975	40,395	41,808
EBITDA ¹	15,822	16,178	17,470	20,620	21,370	21,765	22,292	22,403
EBIT ¹	12,424	12,761	13,399	15,028	16,203	16,945	17,758	18,505
Net income ¹	5,893	6,552	6,717	4,090	7,711	8,540	9,426	9,983
Net Debt ¹	25,272	29,640	53,669	48,126	45,475	41,357	35,479	30,453
Reference price ²	224.97	262.64	288.02	260.64	327.31	426.11	426.11	426.11
Nbr of stocks (in thousands)	563,266	533,579	535,178	537,533	538,481	540,632	-	-
Announcement Date	2/7/22	1/31/23	2/6/24	2/4/25	2/3/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	34.58x	12.46x	26.12x	0.57%	1,077B
JOHNSON & JOHNSON	37.53x	6.26x	17.55x	2.1%	612B
ABBVIE INC.	36.12x	8.31x	17.13x	2.45%	501B
MERCK & CO., INC.	113.84x	6x	25.7x	2.32%	364B
ROCHE HOLDING AG	20.01x	4.88x	12.13x	2.7%	353B
NOVARTIS AG	20.46x	5.37x	13.21x	2.96%	278B
ASTRAZENECA PLC	21.15x	4.27x	12.26x	2.07%	251B
AMGEN INC.	27.06x	6.97x	12.48x	2.37%	230B
GILEAD SCIENCES, INC.	-44.86x	6.85x	26.64x	2.14%	190B
Average	29.54x	6.82x	18.14x	2.19%	428.5B
Weighted average by Cap.	35.12x	7.99x	19.65x	1.87%